content top

New Findings in En-face OCT for the Diagnosis of CSCR

SCIENTIFIC POSTER 2016_New Findings in En-face OCT for the Diagnosis of CSCR Patricia Udaondo Purpose: To analyze the advantages and findings of en face OCT in the diagnosis of central serous corioretinopathy (CSC) cases. Methods: Both fluorescein angiography (FA), a gold standard test for diagnosis in CSC and en face/enhanced depth OCT images were obtained in 30 patients with CSC, analysed and compared. Results: In all patients with CSC...

Read More

Atypical Case of Persistant Subretinal Fluid, Mimicking Acute Exudative Polymorphous Vitelliform Maculopathy or CSC

SCIENTIFIC POSTER 2016_Atypical Case of Persistant Subretinal Fluid, Mimicking Acute Exudative Polymorphous Vitelliform Maculopathy or CSC Philippe Koch Introduction: To describe the case of an atypical persistent subretinal fluid presentation following a macula on retinal detachment (R.D). Results: A 64 y.o woman developed a macula on RD extending from 5 to 11 o’clock, a retinal break at 10 o’clock with the RD threatening the macular...

Read More

Outer Retinal Layers Alterations in Chronic CSCR: OCT Images and Fundus Autofluorescence Findings

SCIENTIFIC POSTER 2016_Outer Retinal Layers Alterations in Chronic CSCR OCT Images and Fundus Autofluorescence Findings Ji-Hye Jang Purpose: To document the alteration of the outer retinal layers and fundus autofluorescence (FAF) change in eyes with chronic central serous chorioretinopathy (CSCR). Methods: Seventeen eyes of fifteen patients with chronic CSCR from January of 2014 to March of 2015 with at least 6 months of follow-up with...

Read More

An Atypical Case of Persistant Subretinal Fluid, Mimicking a Unilateral Acute Exudative Polymorphous Vitelliform Maculopathy or a CSC

                  Introduction: To describe the case of an atypical Persistent Subretinal Fluid presentation following a macula ON R.D. Results: A 64 y.o woman developed a Macula ON retinal detachment extending from 5 to 11 o’clock, with a unique retinal break at 10 o’clock but threatening the Macular area. For such reason, a vitrectomy was realised to drain the subretinal fluid...

Read More

Transitional Aspect of Visual Acuity and Macula Using OCT in CSCR

Chang-Uk Choi_SCIENTIFIC POSTER 2015 Purpose: To predict the changes in visual-acuity and macula after treatment by analyzing four bands, external limiting membrane(ELM), inner and outer segments(IS/OS), cone outer segment tips (COST), retinal pigment epithelium (RPE) in central serous chorioretinopathy using optical coherence tomography (OCT) before and after treatment. Method: The retrospective study consisted of 31 eyes of 29 patients...

Read More

Change in Lifestyle and Oral Eplerenone Treatment for CSCR. A Case Report

Miriam Garcia Fernandez_SCIENTIFIC POSTER 2015_1 Advantages: To increase awareness of the importance of change in lifestyle and relaxation and other alternative stress-reduction techniques, for the improvement of patients with central serous corioretinopathy diagnosis. Moreover, this stress reduction, combined with oral eplerenone treatment can contribute to the complete resolution of this pathology. Methods: One 58-year old man complained...

Read More

Complication Secondary to PDT in a Patient with CSCR

Miriam Garcia Fernandez_SCIENTIFIC POSTER 2015_2 Advantages: To report a case of a patient with a history of central serous chorioretinopathy who developed choroidal neovascularization after photodynamic therapy. Methods: A 54-year-old female presented with progressive diminution of visual acuity in her right eye (RE). A complete ocular examination, including determination of Visual Acuity (VA), anterior and posterior biomicroscopy, optical...

Read More

The Efficacy of Intravitreal Bevacizumab Injection in Patients with Acute CSCR

Seungmin Ha_SCIENTIFIC POSTER 2015 Introduction: Acute central serous chorioretinopathy has different pathogenic concepts and it has no gold standard treatment. Treatment includes focal laser photocoagulation, PDT, and intravitreal anti-VEGF injection. Focal laser can seal the leaking vessels but it can cause scotoma and develop CNV. PDT can be also treatment option but it can cause RPE alterations, CNV, and choroidal ischemia. Anti-VEGF...

Read More

Locational Relationship Between Retinal and Choroidal Changes in CSCR

Don Il Ham_SCIENTIFIC POSTER 2015 Purpose: To investigate three-dimensionally the locational relationship between retinal, retinal pigment epithelial (RPE), and choroidal lesions in eyes with central serous chorioretinopathy. Methods: 14 eyes of 13 subjects diagnosed as central serous chorioretinipathy (CSC) underwent fundus color photography, fluorescein angiography (FA), indocyanine green angiography (IA), and en face OCT (Avanti RTVue...

Read More

Changes in Multifocal Electroretinogram After CSCR

Jae Ryong Han_SCIENTIFIC POSTER 2015 Purpose: To evaluate the changes in mutifocal electroretinogram after resolusion of central serous chorioretinopathy. Method: Thirty-six patients with central serous chorioretinopathy were examined mutifocal electroretinogram after resolusion of the acute phase. Results: Even after complete resolusion of central serous chorioretinopathy, visual acuity and multifocal electroretinogram were improved slowly...

Read More

Long-term Clinical Outcomes of CSCR from a Single Tertiary Centre

Purpose: To present long-term clinical outcomes of patients with central serous chorioretinopathy (CSCR) followed in a single tertiary Centre. Patients and Methods: Forty-two patients diagnosed as acute or chronic CSCR and followed regularly were included into the study. The files of the patients with complete follow-up data were reviewed retrospectively and following parameters were recorded: Age, gender, type, symptom durations, episode...

Read More

En-face OCT in Detection of Photoreceptor Damage in CSCR

Jakub Kaluzny_SCIENTIFIC POSTER 2015 Purpose: To evaluate areas of reduced reflectivity of ellipsoid zone of photoreceptors in eyes with central serous chorioretinopathy (CSCR). Material & Methods: En face OCT reflectivity maps on the level of ellipsoid zone were created in 16 eyes with active stage of the disease and after subretinal fluid absorption. Results: The topography of ellipsoid zone reflectivity reduction corresponded to the...

Read More

Effect of Topical Nonsteroidal Anti-inflammatory Eye Drops (0.1% Pranoprofen) for Acute CSCR

Yoon Hyung Kwon_SCIENTIFIC POSTER 2015 Purpose: To investigate the effect of topical pranoprofen 0.1% in the treatment of acute serous chorioretinopathy. Methods: This was a retrospective review of 52 serous chorioretinopathy cases (52 patients). 26 patients were received topical pranoprofen 0.1% (treatment group); and the other 26 patients did not receive any treatment served as the control group. Baseline and follow-up visual acuity...

Read More

Two Cases of Intravitreal Anti-VEGF for CNV Secondary to Chronic CSCR

Joo Yong Lee_SCIENTIFIC POSTER 2015 Purpose: To report two cases of choroidal neovascularization (CNV) secondary to chronic central serous chorioretinopathy (CSC) treated with anti-vascular endothelial growth factor (VEGF). Methods: Two eyes with CNV associated with chronic CSC were treated with intravitreal injection of ranibizumab (0.5 mg/0.05cc) or bevacizumab (1.25mg/0.05cc) and were evaluated for best corrected visual acuity (BCVA),...

Read More

Photodynamic Therapy and Focal Laser Photocoagulation in CSCR

Youngdo Yeo_SCIENTIFIC POSTER 2015 Purpose: To compare the treatment efficacy of photodynamic therapy (PDT) and focal laser photocoagulation in chronic central serous chorioretinopathy (CSC). Methods: Forty eyes of 40 patients with chronic CSC treated with PDT or focal laser photocoagulation were evaluated retrospectively. Mean change in best corrected visual acuity (BCVA), whether resolution of subretinal fluid (SRF) and pigment epithelium...

Read More

Review of Literature and State of Knowledge

Review of Literature and State of Knowledge

Read More

Focal Choroidal Excavation in Eyes with CSCR

Purpose: To study the prevalence and three-dimensional (3-D) tomographic features of focal choroidal excavations in eyes with central serous chorioretinopathy (CSC) using swept-source optical coherence tomography (OCT). Design: Prospective, cross-sectional study. Methods: We examined 116 consecutive eyes with CSC with a prototype 3-D swept-source OCT. 3-D images of the shape of the macular area, covering 6 x 6 mm2, were reconstructed by...

Read More

Long-term Outcomes of CSCR

Settings: Institut Catala de Retina, Barcelona, Spain Purpose: To describe the characteristics of chronic central serous chorioretinopathy (CCSC) with a long duration of follow-up. Methods: Retrospective analysis of patients diagnosed of CCSC between 2011 and 2014 with foveal involvement and follow-up of at least one year. Results: We included 45 patients (48 eyes) of 233 cases of central serous chorioretinopathy (39.5%). Mean follow-up...

Read More

OCT Angiography of Pigment Epithelial Detachment

Purpose: To noninvasively describe the spectrum of pigment epithelial detachments (PEDs) occurring mainly in age-related macular degeneration (AMD) and central serous chorioretinopathy (CSC) and also in other inflammatory, iatrogenic retinal disorders with Optical Coherence Tomography Angiography (OCTA). Methods: Observational, cross-sectional study of 30 patients with drusenoid, serous, vascularized or mixed PEDs. OCTA was performed on...

Read More

OCT Angiography of CSCR in Elderly Patients

Purpose: To noninvasively describe the features of retinal and choroidal vascular changes in elderly patients with central serous chorioretinopathy (CSC) with Optical Coherence Tomography Angiography (OCTA). Methods: Cross-sectional, observational study of 10 patients between 55 and 64 years of age with central serous chorioretinopathy. OCTA was performed on 3×3 and 6×6 mm area centred on the fovea. The 3D angiography was...

Read More

Diagnostic Accuracy & Risk Factors for Metamorphopsia Using M-CHARTS and Preferential Hyperacuity Perimeter in Patients with Resolved CSCR

Purpose: To compare the diagnostic accuracy and risk factors for metamorphopsia between M-CHARTS and preferential hyperacuity perimeter (PHP) in the patients with resolved central serous chorioretinopathy (CSC). Methods: This study included patients with resolved CSC without macular oedema on optical coherence tomography (OCT). We evaluated metamorphopsia using M-CHARTS and PHP. Foveal microstructure was assessed with spectral-domain OCT...

Read More

CSCR or Not CSCR? This is the Question

Purpose: Whilst the diagnosis of central serous chorioretinopathy (CSCR) is usually straightforward to make, diagnostic challenges do exist. In this presentation, I will discuss several cases that either had CSCR with atypical features or another underlying diagnosis masquerading as CSCR. Contact Details: Email: ahmedsallam11@yahoo.com Cell Phone:...

Read More

CSCR Is Not Always the Same

Purpose: Despite numerous studies describing predominantly its clinical course, many aspects of central serous chorioretinopathy (CSCR) remain unclear. Hypotheses on the pathogenesis of CSCR have ranged from a basic alteration in the choroid to an involvement of the retinal pigment epithelium (RPE). Methods: We reviewed the different therapeutic approaches, including adrenergic antagonists, carbonic anhydrase inhibitors, mifepristone,...

Read More

Two Cases of Atypical Bilateral CSCR

Purpose: Case 1: A 39 year old woman presented with a bilateral slowly deteriorating visual acuity, metamophopsia and micropsia. We diagnosed CSCR and treated with acetazolamid and NSAID. Social history revealed a type A personality (ambitious, freelancer), in addition the patient reported sweating sleeping disorders, nycturia, a prolonged menstruation cycle, development of a moustache and increasing weight, so we suggested an...

Read More

CSCR and Vitelliform Dystrophy as Exudative ARMD Masquerading Diseases

Purpose: There are many entities masquerading ARMD, which have been treated with anti-VEGFs many times without getting any response. In this presentation a chronic CSC and a pattern dystrophy misdiagnosed as exudative ARMD and injected anti-VEGF many times without any success will be presented. Contact Details: Email: sozdek@gazi.edu.tr Cell Phone:...

Read More

CSCR Mimicking Choroiditis

Purpose: A 35 year old young male reported with deceased vision in the right eye for 1.5 months. He had difficulty in reading and doing near work. On examination, BCVA was 20/60 and 20/20 in the right and left eye respectively. Fundus examination showed no vitreous cells and yellowish choroiditis-like lesion at the macula. Patient was taking oral steroid for the lesion. OCT examination showed sensory elevation in both eyes with diffuse...

Read More

Efficacy of PDT in Steroid-associated CSCR: A Case-control Study

Purpose: Corticosteroid exposure has previously been suggested as a risk factor for the development of chronic central serous chorioretinopathy (CSC). In this study we assess whether the therapeutic outcome of half-dose photodynamic therapy (PDT) is different in CSC patients with prior exogenous corticosteroid use or endogenous hypercortisolism as compared to patients without any corticosteroid exposure. Methods: We retrospectively...

Read More

Stimulation Laser in CSCR

Purpose: We use an individualized treatment for CSC based both on traditional procedures and on experimental ones. Laser stimulation therapy can be beneficial even in cases without the typical focus of leakage. In difficult cases without any defined or even anticipated leakage we use experimental therapy with anti-VEGF injections. Even intensive topical steroid therapy, usually strictly rejected, proved to be useful in rare cases. Methods:...

Read More

15 Years Follow-up of a Severe Case of CSCR

Purpose: Severe types of central serous chorioretinopathy (CSC) have a chronic and persisting nature. Multimodal imaging presently allows thorough documentation of apparently quiescent phases, as well as acute exudative episodes. Limited information concerning long-term natural history of severe CSC is available in the literature. The purpose of the Authors is to report clinical and multimodal imaging features of a bilateral, severe case...

Read More

PDT for CSCR: What is the Appropriate Dose?

Purpose: Visudyne is FDA-approved for management of exudative AMD but is probably much more commonly used off-label. According to the manufaturer’s label “Visudyne is not approved for use in other indications, in combination with another product, with reduced fluency, or with any other alteration to administration.” Both for exudative AMD and central serous chorioretinopathy photodynamic therapy with Visudyne is often...

Read More

Full PDT for CSCR

Purpose: We present 7 cases with Central Serous Chorioretinipathy with more than 6 months of evolution. Methods: All of them were treated with Photodynamic Therapy at full dose of 50 J/cm2 and 6 mg/m2. All the patients were visited at 1, 3, 6 and 12 months, only 3 of them came to the 24 month visit. Results: In 6 cases the liquid disappeared completely and in 1 case persisted although it decreased and a better vision was registered. No...

Read More

Half-fluence PDT in the Treatment of Chronic CSCR

Purpose: We carried out a retrospective chart review of all patients with chronic CSC involving the fovea treated with HF-PDT and followed-up at least for 6 months. Methods: Recorded parameters included Best-Corrected Visual Acuity (BCVA) in logMAR, Central Subfield Thickness (CST) by Cirrus OCT and any adverse event occurred at baseline and during follow-up visits. 23 eyes of 23 patients were included. Results: Mean follow-up time (SD,...

Read More

PPV with ILM Removal, Silicone Oil Filling & Face-down Positioning for Refractory CSCR

Purpose: To evaluate the effectiveness of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) removal, silicone oil (SO) placement and face-down positioning for treatment of refractory chronic central serous chorioretinopathy (CSCR). Methods: A retrospective study was performed looking at patients diagnosed with CSCR since 2012. Eyes with non-active CSCR and those that responded to treatment were excluded. Eyes with chronic,...

Read More

Mineralocorticoid Receptor Antagonist Eplerenone for Chronic CSCR

Purpose: To evaluate the efficacy of treatment of chronic central serous retinopathy (CSR) with the mineralocorticoid receptor antagonist eplerenone. Methods: IRB approval was obtained through the University of Minnesota. Subjects with CSR based on symptoms, biomicroscopy, fluorescein angiography (FA) and optical coherence tomography (OCT) were enrolled. Subjects must have had symptoms and subretinal fluid on OCT for at least three months...

Read More

Chronicity and Recurrence Impact in CSCR After PDT

Purpose: To analyse the influence of chronicity and recurrence in structural and functional outcomes in central serous chorioretinopathy (CSC) patients who had half-dose photodynamic therapy (PDT), and to determine the characteristics of patients that recurred after treatment. Methods: A retrospective, observational study included treatment-naïve patients with CSC who received half-dose PDT. Measurements of best-corrected visual acuity...

Read More

Short & Long-term Functional & Anatomic Changes After Half-dose PDT for CSCR

Purpose: To evaluate short and long-term functional and structural changes after half-dose photodynamic therapy (PDT) for central serous chorioretinopathy (CSC) and assess the prognostic effect of episode duration and history of previous episodes. Methods: A retrospective study including acute and chronic CSC treatment-naïve patients submitted to half-dose PDT and followed for at least 6 months. Best corrected visual acuity (BCVA), mean...

Read More

Half-fluence PDT for Chronic CSCR

Purpose: To evaluate the prognostic factors and effect of half-fluence photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC). Methods: We retrospectively reviewed fifty-six eyes of 56 patients with chronic CSC who underwent half-fluence PDT. Postoperative evaluation included improvements in visual acuity, changes in central macular thickness with the optical coherence tomography (OCT), and...

Read More

EVRS CSCR Study Results Barbara Parolini

EVRS CSCR Study Results 

Read More

Methotrexate for the Treatment of Chronic CSCR – Preliminary Results

SCIENTIFIC POSTER_Katarzyna Michalska-Malecka Purpose: The purpose of this study was to evaluate the effectiveness of series of oral low-dose methotrexate for the treatment of chronic central serous chorioretinopathy (CSCR). Methods: This prospective, comparative clinical study included six eyes of 6 patients with symptomatic CSCR who were observed at the Department of Ophthalmology, University Centre of Ophthalmology and Oncology, Medical...

Read More

PDT vs Bevacizumab in Central Serous Chrioretinopathy: Comparison After 12 Months

SCIENTIFIC POSTER_Young Hoon Lee Purpose: In this study we compared the effectiveness between half energy photodynamic therapy (PDT) and intravitreal bevacizumab (IVB) injection for chronic central serous chorioretinopathy (CSC). Methods: Forty-five eyes of 42 patients diagnosed as chronic CSC from March 2008 to April 2011 were treated with half energy PDT or IVB injection. The subjects were chosen for a retrospective study and analysis was...

Read More

Choroidal Neovascularization After PDT in a Patient with Central Serous Chrioretinopathy

SCIENTIFIC POSTER_Miriam Garcia Fernandez_3 Advantages: To report of a case with central serous chorioretinopathy who developed choroidal neovascularization after photodynamic therapy. Methods: A 54-year-old female presented with progressive diminution of visual acuity in her right eye (RE). A complete ocular examination including visual acuity (VA) measurement, anterior and posterior biomicroscopy, optical coherence tomography (OCT) and...

Read More

Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor in Acute Central Serous Chorioretinopathy: One-Year Results

To evaluate the 1-year efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) in patients with acute central serous chorioretinopathy (CSC).

Read More

Functional and Anatomical Effect of Laser and Intravitreal Injection on the Persistence of Serous Macular Detachment

Advantages: The effect of laser and intravitreal injection on the persistence of serous macular detachment and its effect on functional and anatomical results. Methods: Thirty-one diabetic patients who had diabetic retinopathy and clinically significant macular edema with serous macular detachment were included. Data were reviewed for laser treatment (panretinal-grid-focal photocoagulation) and intravitreal injection (triamcinolone...

Read More

ME Secondary to Central Serous Chorioretinopathy Treated by PDT Without Verteporfin

ME Secondary to Central Serous Chorioretinopathy Treated by PDT Without Verteporfin Francisco J. Ascaso Advantages: To get a cost-effectiveness central serous chorioretinopathy (CSC) therapy, reducing the side-effects of verteporfin (allergy, photosensitivity, …), and avoiding its contraindications (pregnancy, liver disease, …). Methods: Eight symptomatic male patients (mean age: 45.1 years, range: 27-63 years) with macular...

Read More

Intravitreal Bevacizumab for Treatment of Chronic Central Serous Chorioretinopathy

Kubilhan Elmas, Özgür Bilen Basaran, Ali Altýnsoy (Ankara, Turkey) The purpose of this study was to evaluate the effectiveness of intravitreal injection of bevacizumab for treatment of central serous chorioretinopathy. Seven eyes of 7 patients with chronic central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits patients had best corrected visual acuity (BCVA),...

Read More

Low-fluence Photodynamic Therapy Can Reduce Metamorphopsia in Central Serous Chorioretinopathy Treatment

Sin Woo Bae, Sung Jae Yang, Ju Byung Chae (Seoul, South Korea) Advantages: To compare metamorphopsia changes after two different central serous chorioretinopathy treatments with M-CHART (Inami Co., Tokyo, Japan). Methods: We compared 20 self-resolved eyes with oral medication and 10 eyes with low-fluence (LF) PDT. M-CHART, best corrected visual acuity (BCVA), and optical coherence tomography (OCT) were investigated. Effectiveness /...

Read More

The Role of Conventional Argon Laser Treatment in Central Serous Chorioretinopathy

Edin Catovic, Edina Barakovic-Catovic, Stefan Malm (Sweden) Advantages: Conventional argon laser treatment can be a useful and powerful tool to treat the different clinical forms of Central Serous Chorioretinopathy (CSC). Methods: Acute CSC: Case 1: acute CSC treated with conventional argon laser: complete resolution of serous retinal detachment (SRD) on OCT and complete restoration of visual acuity (AC).Case 2: recurrent CSC-patient...

Read More

Stimulation Laser in Central Serous Chorioretinopathy

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Ivan Fiser (Prague, Czech Republic) Advantages: We use an individualized treatment for CSC based both on traditional procedures and on experimental ones. Laser stimulation therapy can be beneficial even in cases without the typical focus of leakage. Intensive topical steroid therapy, commonly strictly rejected, proved to be useful in some cases. Methods:...

Read More

Early Laser Treatment and Late Laser Treatment in Central Serous Chorioretinopathy – Results, Spectral Optical Coherence Tomography Findings

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Dominik Odrobina, Janusz Michalewski, Zofia Michalewska, Jerzy Nawrocki (Lodz, Poland) Advantages: Advantages of early laser treatment vs late laser treatment in CSC. Methods: 20 eyes with acute CSC (duration less than 6 months) – Group A, and 15 eyes with chronic CSC (duration more than 6 months) – Group B were included in this study. In every eye we...

Read More

Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Ron A. Adelman, Shelly T. Lee (New Haven, FL, USA) Advantages: Intravitreal injection of bevacizumab may be effective in patients with recurrent central serous chorioretinopathy (CSC). Methods: A retrospective study of patients with a diagnosis of recurrent CSC who were treated with intravitreal bevacizumab from January 2007 – January 2009. 1.5 mg...

Read More

Ranibizumab or Photodynamic Therapy for Central Serous Chorioretinopathy?

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Begoña Pina Marín, José Juan Escobar Barranco, Manel Fernández Bonet (Barcelona, Spain) Advantages: The physiopathology of central serous corioretinopathy (CSC) remains controversial. The traditional treatment includes laser photocoagulation or photodynamic therapy (PDT). Lately, ranibizumab, an anti-VEGF antibody, has shown anti-permeable properties that...

Read More

Transpupillary Thermotherapy for the Treatment of Central Serous Chorioretinopathy

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Salim Ben Yahia, Rim Kahloun, Bechir Jelliti, Salma Gargouri, Sonia Attia, Moncef Khairallah (Monastir, Tunisia) Advantages: To treat central serous chorioretinopathy (CSC) with subthreshold transpupillary thermotherapy (TTT) inducing less damage to the macula than laser photocoagulation. Methods: Ten eyes of 10 patients with persistent serous retinal detachment...

Read More

Bullous Exudative Retinal Detachment Due to Giant Rip of the RPE in Course of Chronic Central Serous Retinopathy, Treated with Photodynamic Therapy

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Enrico Bertelli, Stefano Coser, Veronika Rogger (Bolzano, Italy) Advantages: Various authors have reported that photodynamic therapy (PDT) can be an effective treatment for serous exudation in Central Serous Chorioretinopathy (CSC). This approach is based on the notion that choroidal hyperpermeability, as demonstrated by indocyanine green angiography, is an...

Read More

Utility of Metronomic MTX in Chronic Central Serous Retinopathy

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Shree K. Kurup (Winston Salem, NC, USA), Armando Oliver, Andres Emanuelli, Vincent Hau, David Callanan (San Juan, Puerto Rico) Advantages: Chronic central serous chorioretinopathy (CSR) is a condition that may be difficult to manage with conventional therapy or “off-label” therapy. Methotrexate is a relatively inexpensive drug that is available almost...

Read More

Does Helicobacter Pylori Infection Play a Role in Central Serous Chorioretinopathy Etiopathogenesis?

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Jerzy Mackiewicz, Barbara Skrzydo-Radomañska, Monika Jasielska, Pawel Bieliñski (Lublin, Poland) Advantages: The aim of this study was to determine the relation between gastric Heliobacter pylori (HP) infection and CSC. Methods: Retrospective, comparative, observational case series of 12 patients with CSC during 1.04.2009-31.03.2010. Clinical diagnosis of CSC...

Read More

The Role of Photodynamic Therapy in Central Serous Chorioretinopathy

Isaac Alarcon, Daniel Vilaplana, Vladimir Poposki, M. Castilla, Xavier Acebes (Barcelona, Spain) Advantages: Photodynamic therapy (PDT) can be a useful and powerful tool to treat the different clinical forms of Central Serous Chorioretinopathy (CSC) and its possible complications. Methods: Classic CSC: PDT can be useful to treat CSC specially when the patient suffers more than one episode from the same focal leak in the fundus. We show...

Read More

Acute and Chronic Central Serous Chorioretinopathy – Microstructural Changes in Spectral Optical Coherence Tomography

http://www.evrs.eu/medias/2010/congress/Central-Serous-Chorioretinopathy.flv Dominik Odrobina, Janusz Michalewski, Zofia Michalewska, Jerzy Nawrocki (Lodz, Poland) Advantages: SOCT has important value in analyzing microstructural changes in CSC. Methods: 30 eyes with acute CSC (duration less than 6 months) – Group A, and 25 eyes with chronic CSC (duration more than 6 months) – Group B were included in this study. Effectiveness...

Read More

The Approaches to Central Serous Chorioretinopathy

Authors: Cigdem Altan, Hülya Güngel, Merih Gül, Hakan Eren, Tanýl Gürsel, Eyüp Durgut, Istanbul, Turkey Advantages / Purpose: To present the treatment approaches to cases with central serous chorioretinopathy (CSC). Methods: Twenty-six eyes of 25 patients who were diagnosed as CSC and followed between May 2008 and February 2009 were included in the study. Demographic data, visual acuity and macular thickness, management and...

Read More

The Role of Vitreomacular Traction in Chronic Refractive Central Serous Choroidopathy

http://www.evrs.eu/medias/2008/congress/The-Role-of-Vitreomacular-Traction-in-Chronic-Refractive-Central-Serous-Choroidopathy.flv Ioannis P. Theocharis Advantages: Vitrectomy may be beneficial in cases with recurrent chronic CSC when partial PVD is documented with the new spectral domain OCT. Methods: PPV and PVD with ILM peeling in a case with diffuse chronic central pigment epitheliopathy where vitreous attachments are documented with...

Read More

Photodynamic Therapy for Iatrogenic Choroidal Neovascularization Associated with Laser Photocoagulation in Central Serous Chorioretinopathy

Osman Cekic, Mehmet Cakir, Omer F. Yilmaz Advantages: To report the result of photodynamic therapy (PDT) for an iatrogenic choroidal neovascularization (CNV) complicating focal argon laser coagulation in a case with central serous chorioretinopathy. Methods: A 45-year-old woman that developed CNV upon focal argon laser photocoagulation for chronic central serous chorioretinopathy was treated with ocular PDT with verteporfin. Effectiveness...

Read More

Central Serous Chorioretinopathy Following Unusual Routes of Administration of Exogenous Steroids

Manjot Gill, MD (Chicago, IL), Rukhsana Mirza, MD (Chicago, IL) PURPOSE: To describe three cases of central serous chorioretinopathy following atypical routes of adminstration of exogenous steroids. This includes the first reported case of a patient who developed CSCR following intra-scalp steroid injection as well as the first described case of CSCR following use of steroid shampoo. METHODS: This was a retrospective case series describing...

Read More

Fundus Autofluorescence in Central Serous Chorioretinopathy

Seung-Young Yu, MD, PhD (Seoul, Korea), Sang-Woong Moon, MD (Seoul, Korea), Won Ki Lee, MD, PhD (Seoul, Korea), Hyung-Woo Kwak, MD, PhD (Seoul, Korea) PURPOSE: To describe the fundus autofluorescence (FAF) patterns in patients with central serous chorioretinopathy (CSC) and compare them with the findings of optical coherent tomography (OCT), fluorescein angiography (FA), and indocyanine green angiography (ICG). METHODS: The FAF images were...

Read More

Optical Coherence Tomography (OCT) Findings in Central Serous Chorioretinopathy (CSC) and Rhegmatogenous Retinal Detachment (RRD)

Sun Young Lee, MD (Seoul, South Korea), Young Hee Yoon, MD (Songpa-ku, Korea), Soo Geun Joe, MD (Seoul, South Korea), Hye Won Chung, MD (Seoul, South Korea), Jun-Gone Kim, MD (Seoul, South Korea) SYNOPSIS CSC and RRD typically show sensory retinal detachment however, pathogenic mechanism and level of visual impairment are different despite macular involvement in both diseases. Here we sought to assess OCT findings in CSC and RRD. High...

Read More

Therapeutic Effect of Propranolol on Central Serous Chorioretinopathy

Ali R. Ramezani, MD, Hamid Ahmadieh, MD Purpose: To evaluate the therapeutic effect of propranolol on central serous chorioretinopathy (CSCR). Methods: In a prospective interventional case series, 18 eyes with CSCR received 40 mg/day propranolol for 6 weeks. Complete ophthalmologic examination was performed before intervention and at 2 and 6 months. The outcome measures were retinal neurosensory detachment size, evaluated by paired t-test,...

Read More
content top